Electropharmacologic Characteristics of Ventricular Proarrhythmia Induced by Ibutilide
- 1 August 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 34 (2) , 237-247
- https://doi.org/10.1097/00005344-199908000-00009
Abstract
The purpose of this study was to evaluate in vivo the proarrhythmic effects of ibutilide in dogs with or without ventricular hypertrophy. Fourteen dogs received repeated experiments both during the acute and chronic phases (8 weeks, with ventricular hypertrophy) of complete atrioventricular (AV) block. Twelve-lead ECG, monophasic action potentials in the left and right ventricle were recorded before and after each dose of ibutilide (0.01-0.08 mg/kg) during different ventricular rates. In these dogs, ibutilide increased QT interval, biventricular APD90, interventricular ΔAPD90 (difference between the left and right ventricular APD90), and QT dispersion, and induced early afterdepolarizations in a dose-dependent manner. The interventricular ΔAPD90, QT dispersion, and increases of QT interval were more pronounced during slower ventricular rates. There were greater QT interval, biventricular APD90, interventricular ΔAPD90, and QT dispersion values during chronic AV block than during acute AV block. Moreover, ibutilide can induce higher incidences of early afterdepolarizations and torsades de pointes [six (43%) of 14 versus 0 of 14; pKeywords
This publication has 32 references indexed in Scilit:
- Efficacy of Ibutilide for Termination of Atrial Fibrillation and FlutterThe American Journal of Cardiology, 1996
- Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/FlutterThe American Journal of Cardiology, 1996
- Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or FibrillationCirculation, 1996
- Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response studyJournal of the American College of Cardiology, 1996
- QT Dispersion: Problems of Methodology and Clinical SignificanceJournal of Cardiovascular Electrophysiology, 1994
- The QT Interval and Drug-Associated Torsades de PointesClinical Drug Investigation, 1993
- Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.Circulation, 1990
- Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations?Journal of the American College of Cardiology, 1989
- When is QT prolongation antiarrhythmic and when is it proarrhythmic?The American Journal of Cardiology, 1989
- Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.Circulation, 1981